advertisement

Topcon

Zaman F 1

Showing records 1 to 1 | Display all abstracts from Zaman F

55736 Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials
Myers JS; Vold S; Zaman F; Williams JM; Hollander DA
Clinical Ophthalmology 2014; 8: 643-652

Issue 15-4

Change Issue


advertisement

Oculus